Product Program year 2024 Source: CMS Open Payments

Propel

Device Otolaryngology (Ear, Nose, Throat)

PDI M927700110

Open in the dashboard

General payments

$857,180

5,315 payments

Research payments

$419,966

105 payments

Through program year 2024, $857,180 in general payments and $419,966 in research payments were reported against Propel (Otolaryngology (Ear, Nose, Throat)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $252,739 1,336
2023 General $400,877 2,262
2023 Research $10,063 8
2022 General $203,565 1,717
2022 Research $409,904 97

Breakdown

Who paid General payments · program years 2022–2024
  1. Medtronic, Inc. $784,698 4,531 payments
  2. Intersect ENT, Inc. $72,483 784 payments
Top recipients General payments · program year 2024
  1. Roheen Raithatha Otolaryngology · New York, NY $38,050 15% · 38 payments
  2. Keith Matheny Otolaryngology · Frisco, TX $27,000 11% · 9 payments
  3. Greg Davis Otolaryngology · Puyallup, WA $17,564 7% · 18 payments
  4. David Conley Otolaryngology · Chicago, IL $11,812 5% · 12 payments
  5. Nipun Chhabra Otolaryngology · Leesburg, VA $11,599 5% · 22 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Otolaryngology $230,938 92% · 612 practitioners
  2. Plastic Surgery within the Head & Neck Otolaryngology $9,882 4% · 26 practitioners
  3. Otolaryngology/Facial Plastic Surgery Otolaryngology $3,751 1% · 47 practitioners
  4. Pediatric Otolaryngology Otolaryngology $1,675 <1% · 15 practitioners
  5. Facial Plastic Surgery Otolaryngology $789 <1% · 15 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $57,658 23% · 121 recipients
  2. New York $45,111 18% · 59 recipients
  3. Washington $27,140 11% · 22 recipients
  4. Ohio $18,533 7% · 26 recipients
  5. California $15,893 6% · 59 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

5,315 general · 105 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record